Aprogen pharmaceuticals,Inc. (KOSE:A003060) agreed to acquire Aprogen Biologics Inc. from Aprogen, Inc. on October 4, 2022. The deal is subject to Aprogen pharmaceuticals,Inc. (KOSE:A003060) board approval. As of October 4, 2022 Aprogen pharmaceuticals,Inc. (KOSE:A003060) board approved the deal.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,011 KRW | +0.60% | -0.79% | -65.14% |
1st Jan change | Capi. | |
---|---|---|
-65.14% | 47.95M | |
+56.86% | 815B | |
+43.90% | 641B | |
-6.57% | 352B | |
+17.32% | 314B | |
+9.94% | 303B | |
+16.08% | 242B | |
+2.29% | 224B | |
+13.96% | 218B | |
+7.98% | 168B |
- Stock Market
- Equities
- A003060 Stock
- News Aprogen Biologics Inc.
- Aprogen pharmaceuticals,Inc. agreed to acquire Aprogen Biologics Inc. from Aprogen, Inc.